Holtzman Michael J, Byers Derek E, Alexander-Brett Jennifer, Wang Xinyu
1] Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri 63110, USA. [2] Department of Cell Biology, Washington University School of Medicine, Saint Louis, Missouri 63110, USA.
Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri 63110, USA.
Nat Rev Immunol. 2014 Oct;14(10):686-98. doi: 10.1038/nri3739. Epub 2014 Sep 19.
An abnormal immune response to environmental agents is generally thought to be responsible for causing chronic respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). Based on studies of experimental models and human subjects, there is increasing evidence that the response of the innate immune system is crucial for the development of this type of airway disease. Airway epithelial cells and innate immune cells represent key components of the pathogenesis of chronic airway disease and are emerging targets for new therapies. In this Review, we summarize the innate immune mechanisms by which airway epithelial cells and innate immune cells regulate the development of chronic respiratory diseases. We also explain how these pathways are being targeted in the clinic to treat patients with these diseases.
一般认为,对环境因素的异常免疫反应是导致慢性呼吸道疾病的原因,如哮喘和慢性阻塞性肺疾病(COPD)。基于对实验模型和人类受试者的研究,越来越多的证据表明,先天免疫系统的反应对于这类气道疾病的发展至关重要。气道上皮细胞和先天免疫细胞是慢性气道疾病发病机制的关键组成部分,并且正在成为新疗法的靶点。在本综述中,我们总结了气道上皮细胞和先天免疫细胞调节慢性呼吸道疾病发展的先天免疫机制。我们还解释了这些途径在临床上是如何作为治疗这些疾病患者的靶点的。